SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

Incannex Healthcare is trending as it approaches Nasdaq compliance following its recent reverse split, a key de-risking event that has ignited community discussion around its low float. Investors are eagerly anticipating imminent FDA End-of-Phase 2 feedback for its promising IHL-42X sleep apnea drug, fueling speculation of a potential short squeeze and significant upside.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is actively discussed following its first GAAP profitable quarter, strong Q4 performance, and a new $500M stock buyback, with bulls optimistic about its Agentic AI direction and potential government contracts, while others express concern over conservative revenue guidance.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending due to escalating Middle East tensions and reports of oil tanker attacks near the Strait of Hormuz, which are fueling significant supply disruption fears. The community is actively debating if historic global oil reserve releases will be enough to counter these mounting geopolitical risks.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending due to persistent acquisition rumors from major pharmaceutical companies like Eli Lilly and AstraZeneca, fueled by reports from a reputable French publication, highlighting its promising ulcerative colitis treatment and robust clinical data. The community is actively discussing a potential bidding war given the drug's innovative profile and upcoming data presentations, positioning it as a highly attractive target in the biotech sector.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending as escalating Middle East tensions and attacks on oil tankers in the Strait of Hormuz fuel fears of higher energy prices and broader inflation, while many in the community express frustration over perceived market manipulation and daily "V-shaped" recoveries that defy negative news.

EHang Holdings Ltd. engages in the provision of aerial vehicle technology platform company. It also provides unmanned aerial vehicle (UAV) systems and solutions: air mobility (including human transportation and logistics), smart city management, and aerial media solutions. The firm operates through the following geographical segments: P.R.C., West Asia, East Asia, South America, Europe, and Other. The company was founded by Huazhi Hu and Yifang Derrick Xiong in December 2014 and is headquartered in Guangzhou, China.

EHang Holdings Ltd - ADR

EHang Holdings

EHang Holdings is trending as China designates the low-altitude economy a national pillar industry, highlighting the company's certified, pilotless eVTOLs and record deliveries, with the community actively discussing its perceived undervaluation amidst accelerating commercial operations and the debut of its new long-range VT35.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as investors react to the appointment of Josh D'Amaro as its new CEO and robust Q1 earnings, particularly record revenue from its Parks division, fueling community debate on its valuation, strategic direction, and anticipated share buybacks.

ProFrac Holding Corp. engages in the provision of hydraulic fracturing, proppant production, and other completion services. It operates through the following segments: Stimulation Services, Proppant Production, Manufacturing, and Other. The Stimulation Services segment owns a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services to customers. The Proppant Production segment focuses on the provision of proppant to oilfield service providers and exploration and production companies. The Manufacturing segment is involved in the sale of products such as horsepower pumps, valves, piping, swivels, large-bore manifold systems, and fluid ends. The Other segment refers to Flotek Industries and Livewire Power, LLC. The company was founded in 2016 and is headquartered in Willow Park, TX.

ProFrac Holding Corp - Ordinary Shares - Class A

PROFRAC HOLDING CORP

ProFrac Holding Corp (ACDC) is trending following its Q4 2025 earnings report, which delivered a revenue beat against analyst estimates but also a GAAP EPS decline and a softer Q1 2026 outlook due to weather disruptions. The community is actively debating if the revenue upside can offset profitability concerns and previous underperformance, especially given its position in the volatile oilfield services sector.

Smart Lending AI (SLAI) is a decentralized on-chain lending protocol that lets users lock approved tokens and instantly borrow up to 50% of their USD value in ETH—without selling. Prices are calculated directly on-chain via WETH pairs, and loan risk is managed through real-time volatility and liquidity analysis. Borrowers pay a flat 5% interest, while SLAI stakers (≥50,000 tokens) enjoy zero interest benefits. Designed for active DeFi traders, SLAI enables fast, gas-efficient liquidity access while preserving token exposure.

Smart Lending AI

Smart Lending AI (SLAI) is trending after receiving a preliminary going-private proposal offering a premium over its recent trading prices, sparking community debate over a potential low-ball buyout and a significant shift in voting power to its founder. This is compounded by discussions around a strategic pivot into AI and blockchain, adding to investor interest.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending due to significant executive share sales and widespread community discontent with management following a challenging financial update, as investors weigh uncertainty around a potential POSCO strategic partnership and evolving tariff discussions against current debt levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunovant Stock Surges 17% in 3 Months: What's Driving It?

IMVT gains 17% in three months as IMVT-1402 advances across autoimmune trials, with multiple data readouts due in 2026-2027, and $994.5M cash backing development.

AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know 

Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships for international growth fuel optimism.

Is Assertio (ASRT) Outperforming Other Medical Stocks This Year?

Here is how Assertio (ASRT) and Aura Biosciences, Inc. (AURA) have performed compared to their sector so far this year.

Assertio (ASRT) Projected to Post Quarterly Earnings on Wednesday

Assertio (NASDAQ:ASRT) will be releasing its Q4 2025 earnings before the market opens on Wednesday, March 11. (View Earnings Report at...

Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026

Assertio Holdings, Inc. (Assertio) (Nasdaq: ASRT) today announced that it will release fourth quarter and full year 2025 financial results on Monday, March 16, 2026, after the market close. Following...

REGN & SNY's Dupixent Gets CHMP Nod for Pediatric Use in Urticaria 

Regeneron and Sanofi win CHMP backing to expand Dupixent use to young CSU patients, with EU and U.S. decisions poised to unlock a new growth avenue.

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology Q4 earnings top estimates with 28% revenue jump, but weak 2026 outlook sparks 14% after-hours plunge.

PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View

Perrigo misses Q4 EPS estimates. Its 2026 sales and profit estimates are below expectations as Infant Formula headwinds persist. Shares slide on weak guidance.


Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?

Lipocine (LPCN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss 

AMRN swings to Q4 profit and beats estimates, but revenues decline 21% as Vascepa sales slide and shares fall 9% on the mixed results.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

ASRT
Assertio Holdings Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASRT News

ASRTAssertio Holdings Inc